Photodynamic therapy in young patients

Ophthalmic Surgery Lasers and Imaging

Volumn 37, Issue 3, 2006, Pages 182-189

  Lam, Andrew ^a   Lee, Henry C ^a   Ho, Allen C ^a,b   Regillo, Carl D ^a   McNamara, J Arch ^a   Fineman, Mitchell D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Retinovitreous Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; TRIAMCINOLONE ACETONIDE;

ADULT; ANGIOID STREAK; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MALE; OCULAR HISTOPLASMOSIS; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; REVIEW; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY;

EID: 33745074377     PISSN: 15428877     EISSN: None     Source Type: Journal    
DOI: 10.3928/15428877-20060501-01     Document Type: Review

References (20)

1. Treatment of Age-Related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials. TAP Report. Arch Ophthalmol. 1999;117:1329-1345.
2. Verteporfin in Photodynamic Therapy Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization. VIP Report No. 2. Am J Ophthalmol. 2001;131:541-560.
3. Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ. Etiology of choroidal neovascularization in young patients. Ophthalmology. 1996;103:1241-1244.
4. Verteporfin in Photodynamic Therapy Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: 1-year results of a randomized clinical trial. VIP Report No. 1. Ophthalmology. 2001;108:841-852.
5. Rogers AH, Duker JS, Nichols N, Baker BJ. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology. 2003;110:1315-1320.
6. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol. 2000;117:327-336.
7. Karacorlu M, Karacorlu S, Ozdemir H, Mat C. Photodynamic therapy with verteporfin for choroidal neovascularization in patients with angioid streaks. Am J Ophthalmol. 2002;134:360-366.
8. Shaikh S, Ruby AJ, Williams GA. Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks. Am J Ophthalmol. 2003;135:1-6.
9. Mennel S, Schmidt JC, Meyer CH. Therapeutic strategies in choroidal neovascularizations secondary to angioid streaks. Am J Ophthalmol. 2003;136:580-582.
10. Menchini U, Virgili G, Introini U, et al. Outcome of choroidal neovascularization in angioid streaks after photodynamic therapy. Retina. 2004;24:763-771.
11. Spaide RF, Martin ML, Slakter J, et al. Treatment of idiopathic subfoveal choroidal neovascular lesions using photodynamic therapy with verteporfin. Am J Ophthalmol. 2002;134:62-68.
12. Chan WM, Lam DS, Wong TH, et al. Photodynamic therapy with verteporfin for subfoveal idiopathic choroidal neovascularization: one-year results from a prospective case series. Ophthalmology. 2003;110:2395-2402.
13. Ho AC, Yannuzzi LA, Pisicano K, DeRosa J. The natural history of idiopathic subfoveal choroidal neovascularization. Ophthalmology. 1995;102:782-789.
14. Saperstein DA, Rosenfeld PJ, Bressler NM, et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology. 2002;109:1499-1505.
15. Busquets MA, Shah GK, Wickens J, et al. Ocular photodynamic therapy with verteporfin for choroidal neovascularization secondary to ocular histoplasmosis syndrome. Retina. 2003;23:299-306.
16. Spaide RF, Freund KB, Slakter J, Sorenson J, Yannuzzi LA, Fisher Y. Treatment of subfoveal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina. 2002;22:545-549.
17. Wachtlin J, Heimann H, Behme T, Foerster MH. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol. 2003;241:899-906.
18. Parodi MB, DiCrecchi L, Lanzetta P, Polito A, Bardello F, Ravalico G. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization associated with multifocal choroiditis. Am J Ophthalmol. 2004;138:263-269.
19. Bakri SJ, Beer PM. Photodynamic therapy with verteporfin for classic neovascularization secondary to focal laser photocoagulation for radiation retinopathy. Ophthalmic Surg Lasers Imaging. 2003;34:475-477.
20. Olk RJ, Burgess DB, McCormick PA. Subfoveal and juxtafoveal subretinal neovascularization in the presumed ocular histoplasmosis syndrome: visual prognosis. Ophthalmology. 1984;91:1592-1602.